{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:14:52Z","timestamp":1778667292267,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Nicotinamide adenine dinucleotide (NAD+) is a metabolite of vitamin B3 necessary for the production of key hormones like estradiol. Both NAD+ and estradiol levels decrease with age. Reduced estradiol levels have been associated with undesirable symptoms of the menopause transition. Previous clinical trials have demonstrated that oral supplementation with NRPT, a combination of the NAD+ precursor nicotinamide riboside (NR) plus pterostilbene (PT), significantly increases NAD+ levels. In the present study, the effects of a 7-day supplementation of NRPT on undesirable symptoms of the menopause transition were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An open-label, pilot clinical trial (\n                      <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                      identifier NCT04841499) was conducted to assess the efficacy of NRPT supplementation (commercially known as Basis; a combination of nicotinamide riboside and pterostilbene) in 40 healthy women over 35 years of age, 32 of which self-reported symptoms associated with the menopause transition (MS group) and eight women who were not experiencing any (or minimal) symptoms associated with menopause (No-MS group). All 40 women were given the recommended dose of NRPT (250\u00a0mg NR and 50\u00a0\u00a0mg\u00a0PT) daily for 7\u00a0days. A menopausal symptom survey was taken at baseline and at the end of the 7-day intervention. Urine was also collected at baseline and after 7\u00a0days to assess levels of estrone (E1) and estradiol (E2) and the changes in the vitamin B3 catabolome stemming from NRPT supplementation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At the end of the study, significant decreases in both the frequency and magnitude of bloating, hot flashes, and poor sleep were reported in the MS group as compared to baseline. This was accompanied by a significant increase in the E2\/E1 ratio. The No-MS group did not report any significant changes in these endpoints. As anticipated NRPT intake significantly increased urinary levels of methyl-nicotinamide (Me-NAM) as well as the methylated pyridone carboxamides (Me-PYs) in all groups. A significant time x menopausal status interaction was observed for nicotinuric acid (NUA). No other significant changes occurred for the other nicotinamide catabolites, such as nicotinamide N-oxide (NAM-N-Oxide), and a newly characterized NAD\n                      <jats:sup>+<\/jats:sup>\n                      catabolite, N-methyl-nicotinuric acid (Me-NUA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study demonstrates that NRPT is effective in significantly decreasing the frequency and magnitude of undesirable symptoms of the menopause transition and significantly increases the E2\/E1 ratio in menopausal women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fragi.2026.1773667","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:34:54Z","timestamp":1778664894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial"],"prefix":"10.3389","volume":"7","author":[{"given":"Holly E.","family":"Holmes","sequence":"first","affiliation":[{"name":"Elysium Health","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Elysium Health","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Scalici","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyothi","family":"Dhuguru","sequence":"additional","affiliation":[{"name":"Mitchell Cancer Institute, University of South Alabama","place":["Mobile, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson E.","family":"Shea","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of South Alabama","place":["Mobile, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie E.","family":"Migaud","sequence":"additional","affiliation":[{"name":"Mitchell Cancer Institute, University of South Alabama","place":["Mobile, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan W.","family":"Dellinger","sequence":"additional","affiliation":[{"name":"Elysium Health","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1472-6882-13-238","article-title":"Protective effect of pterostilbene against free radical mediated oxidative damage","volume":"13","author":"Acharya","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0186459","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers","volume":"12","author":"Airhart","year":"2017","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e210537","DOI":"10.1530\/EC-21-0537","article-title":"Menopause-associated risk of cardiovascular disease","volume":"11","author":"Anagnostis","year":"2022","journal-title":"Endocr. Connect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/13697137.2012.688078","article-title":"Health-related quality of life of women with menopausal hot flushes and night sweats","volume":"16","author":"Ayers","year":"2013","journal-title":"Climacteric"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010314","article-title":"Systemic oxidative stress is increased in postmenopausal women and independently associates with homocysteine levels","volume":"21","author":"Bourgonje","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030504","article-title":"Cytoplasmic and mitochondrial NADPH-coupled redox systems in the regulation of aging","volume":"11","author":"Bradshaw","year":"2019","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1757-2215-7-52","article-title":"Immunoexpression of aromatase cytochrome P450 and 17beta-hydroxysteroid dehydrogenase in women's ovaries after menopause","volume":"7","author":"Brodowska","year":"2014","journal-title":"J. Ovarian Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","article-title":"Management of menopausal symptoms: a review","volume":"329","author":"Crandall","year":"2023","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41514-017-0016-9","article-title":"Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study","volume":"3","author":"Dellinger","year":"2017","journal-title":"NPJ Aging Mech. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.32778","article-title":"Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: a double-blind, placebo-controlled clinical trial","volume":"78","author":"Dellinger","year":"2023","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD(+) metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/GME.0000000000000434","article-title":"Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the midlife Women's health study","volume":"22","author":"Gallicchio","year":"2015","journal-title":"Menopause"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101710","DOI":"10.1016\/j.smrv.2022.101710","article-title":"The role of ovarian hormones in the pathophysiology of perimenopausal sleep disturbances: a systematic review","volume":"66","author":"Haufe","year":"2022","journal-title":"Sleep. Med. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12961","DOI":"10.1111\/phpp.12961","article-title":"Inhibition of UVB radiation-induced tissue swelling and immune suppression by nicotinamide riboside and pterostilbene","volume":"40","author":"Isak","year":"2024","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1006\/bbrc.1999.0704","article-title":"Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH","volume":"259","author":"Jin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"E1044","DOI":"10.1210\/jc.2010-2503","article-title":"Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition","volume":"96","author":"Joffe","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsbmb.2010.12.013","article-title":"17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development","volume":"125","author":"Marchais-Oberwinkler","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e180073","DOI":"10.1172\/JCI180073","article-title":"Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations","volume":"134","author":"Mauvais-Jarvis","year":"2024","journal-title":"J. Clin. Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6759000","DOI":"10.1155\/2021\/6759000","article-title":"Estrogenic and antioxidant activities of Pterocarpus soyauxii (Fabaceae) heartwood aqueous extract in bilateral oophorectomized Wistar rat","volume":"2021","author":"Mengue Ngadena","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","article-title":"Regulation of and challenges in targeting NAD(+) metabolism","volume":"25","author":"Migaud","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.3390\/molecules27196316","article-title":"New insights into dietary pterostilbene: sources, metabolism, and health promotion effects","volume":"27","author":"Nagarajan","year":"2022","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s12035-020-02188-7","article-title":"Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1(G93A) mice","volume":"58","author":"Obrador","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e33843","DOI":"10.1016\/j.heliyon.2024.e33843","article-title":"Pterocarpus soyauxii (Fabaceae) aqueous extract to prevent neuropsychiatric disorders associated with menopause by triggering ROS-dependent oxidative damage and inhibiting acetylcholinesterase, GABA-transaminase, and monoamine oxidase A: in vitro,, in vivo,, and in silico approaches","volume":"10","author":"Owona","year":"2024","journal-title":"Heliyon"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e202403384","DOI":"10.1002\/cbdv.202403384","article-title":"Exploring the effects of Pterocarpus soyauxii against menopause-related NAFLD based on network pharmocology, molecular docking, and experimental validation","volume":"22","author":"Owona","year":"2025","journal-title":"Chem. and Biodivers."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1080\/14656566.2024.2383639","article-title":"Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause","volume":"25","author":"Palacios","year":"2024","journal-title":"Expert Opin. Pharmacother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13300-024-01546-1","article-title":"Menopausal hormone therapy in women with type 2 diabetes mellitus: an updated review","volume":"15","author":"Paschou","year":"2024","journal-title":"Diabetes Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1007\/s11033-022-07369-2","article-title":"Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway","volume":"49","author":"Preethi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","article-title":"The menopause transition: signs, symptoms, and management options","volume":"106","author":"Santoro","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/gme.0b013e3181bf5a62","article-title":"Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center","volume":"17","author":"Seritan","year":"2010","journal-title":"Menopause"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.108.776823","article-title":"Hot flashes and subclinical cardiovascular disease: findings from the study of Women's health across the nation heart study","volume":"118","author":"Thurston","year":"2008","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1647721","DOI":"10.3389\/frph.2025.1647721","article-title":"A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women","volume":"7","author":"Vani","year":"2025","journal-title":"Front. Reprod. Health"}],"container-title":["Frontiers in Aging"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2026.1773667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:34:57Z","timestamp":1778664897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2026.1773667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":33,"alternative-id":["10.3389\/fragi.2026.1773667"],"URL":"https:\/\/doi.org\/10.3389\/fragi.2026.1773667","relation":{},"ISSN":["2673-6217"],"issn-type":[{"value":"2673-6217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1773667"}}